Company intelligence / Profile preview

Nūmi

Suresnes (and Paris mentioned), Francenumi.life ↗

Ownership: Private
Development stage: Preclinical

Overview

Nūmi is developing cell-based breast milk to replace traditional bovine infant formula. The company is currently in R&D phase and plans to initially launch its product in the US due to a more welcoming regulatory environment for novel food innovations[3].

Therapeutic areas: Gastroenterology
Modalities: Cell-cultured breast milk
Industry: Food & Nutrition

Partnerships

Collaborations with hospitals and lactariums for sourcing mammary cells[3]

Beyond the preview

Go deeper on Nūmi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nūmi.

Explore the full profile